For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, ...

A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment ...

Oncopeptides AB ( ($SE:ONCO) ) just unveiled an update. Oncopeptides AB announced that a panel of multiple myeloma experts has endorsed the use of ...

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...

This approval marks a milestone for high-risk sMM patients, but analyst Biswajit Podder notes that there are caveats to its ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

Multiple myeloma can relapse two or more times, and tends to become more aggressive and more treatment-resistant with each ...

The FDA has approved daratumumab and hyaluronidase-fihj monotherapy as treatment for adults with high-risk smoldering ...